1. Two Preferentially Expressed Proteins Protect Vascular Endothelial Cells from an Attack by Peptide-Specific CTL.
- Author
-
Thommen, Daniela S., Schuster, Heiko, Keller, Mario, Kapoor, Sarika, Weinzierl, Andreas O., Chennakesava, Cuddapah S., Xueya Wang, Rohrer, Lucia, Von Eckardstein, Arnold, Stevanovic, Stefan, and Biedermann, Barbara C.
- Subjects
- *
ENDOTHELIUM , *PEPTIDES , *MAJOR histocompatibility complex , *LYMPHOBLASTOID cell lines , *CELL death , *SMALL interfering RNA , *HLA histocompatibility antigens - Abstract
Vascular endothelial cells (EC) are an exposed tissue with intimate contact with circulating Ag-speciflc CTL. Experimental in vitro and clinical data suggested that endothelial cells present a different repertoire of MHC class I-restricted peptides compared with syngeneic leukocytes or epithelial cells. This endothelial-specific peptide repertoire might protect EC from CTL-mediated cell death. The HLA-A*02-restricted peptide profile of human EC and syngeneic B lymphoblastoid cells was biochemically analyzed and compared. For EC selective peptides, source protein expression, peptide binding affinity, and peptide-HLA-A*02 turnover were measured. The significance of abundant peptide presentation for target cell recognition by immunodominant CTL was tested by small interfering RNA treatment of EC to knock down the source proteins. High amounts of two peptides, PTRF56-64 and CD59106-114, were consistently detected in EC. This predominance of two endothelial peptides was explained by cell type-specific source protein expression that compensated for poor HLA-A*02 binding affinity and short half-live of peptide/HLA-A*02 complexes. Knocking down the source proteins containing the abundant endothelial peptide motifs led to a nearly 100-fold increase of surface expression of SMCY311-319, an immunodominant minor histocompatibility Ag, as detected by cytotoxicity assays using SMCY311-319 specific CTL. We conclude that EC express and present preferentially two distinct HLA-A*02-restricted peptides at extraordinary high levels. These abundant self-peptides may protect EC from CTL-mediated lysis by competing for HLA-A*02 binding sites with immunodominant scarcely expressed antigenic peptides. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF